报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 3.27% | -33.13% | 40.34% | 75/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 2.33% | 3.1% | 395.74% | 70/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.47% | -34.72% | -91.39% | 89/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 5.46% | 14.23% | 11.66% | 64/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 4.89% | -14.06% | 116.37% | 63/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 2.26% | -16.61% | 213.89% | 73/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 0.72% | -58.86% | -84.94% | 94/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 4.78% | -54.69% | -15.99% | 91/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 5.69% | -48.51% | 109.96% | 81/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 2.71% | -61.17% | 54.86% | 87/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.75% | -28.57% | -83.41% | 73/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 10.55% | -56.08% | -4.52% | 77/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 11.05% | -25.99% | 58.31% | 53/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 6.98% | 66.59% | 184.9% | 57/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 2.45% | 2% | -89.8% | 64/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 24.02% | -35.06% | 60.88% | 40/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 14.93% | 2% | 256.32% | 39/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 4.19% | 2% | -88.67% | 76/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2019-12-31 | 36.99% | -3.4% | -3.4% | 5/129 | 14.38% | 圣湘生物 | 29.33% | 行业排名> |
2018-12-31 | 38.29% | 21.48% | 21.48% | 6/129 | 12.98% | 健尔康 | 84.09% | 行业排名> |
2017-12-31 | 31.52% | 2% | 2% | 12/129 | 13.82% | 祥生医疗 | 28.56% | 行业排名> |